Ligand Pharmaceuticals Incorporated (FRA:LGDN)

Ligand Pharmaceuticals Statistics

Total Valuation

FRA:LGDN has a market cap or net worth of EUR 3.33 billion. The enterprise value is 3.15 billion.

Market Cap	3.33B
Enterprise Value	3.15B

Important Dates

The next estimated earnings date is Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	19.68M
Shares Outstanding	n/a
Shares Change (YoY)	+6.20%
Shares Change (QoQ)	+3.53%
Owned by Insiders (%)	2.13%
Owned by Institutions (%)	100.73%
Float	19.26M

Valuation Ratios

The trailing PE ratio is 80.54 and the forward PE ratio is 28.82.

PE Ratio	80.54
Forward PE	28.82
PS Ratio	15.57
PB Ratio	4.12
P/TBV Ratio	6.36
P/FCF Ratio	127.20
P/OCF Ratio	122.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 64.02, with an EV/FCF ratio of 120.19.

EV / Earnings	76.10
EV / Sales	14.58
EV / EBITDA	64.02
EV / EBIT	167.97
EV / FCF	120.19

Financial Position

The company has a current ratio of 24.69, with a Debt / Equity ratio of 0.47.

Current Ratio	24.69
Quick Ratio	23.66
Debt / Equity	0.47
Debt / EBITDA	7.02
Debt / FCF	14.66
Interest Coverage	7.57

Financial Efficiency

Return on equity (ROE) is 5.42% and return on invested capital (ROIC) is 1.60%.

Return on Equity (ROE)	5.42%
Return on Assets (ROA)	1.48%
Return on Invested Capital (ROIC)	1.60%
Return on Capital Employed (ROCE)	1.99%
Revenue Per Employee	3.15M
Profits Per Employee	608,906
Employee Count	68
Asset Turnover	0.21
Inventory Turnover	6.74

Taxes

In the past 12 months, FRA:LGDN has paid 12.27 million in taxes.

Income Tax	12.27M
Effective Tax Rate	22.86%

Stock Price Statistics

The stock price has increased by +49.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+49.57%
50-Day Moving Average	160.08
200-Day Moving Average	119.59
Relative Strength Index (RSI)	49.18
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.19

Income Statement

In the last 12 months, FRA:LGDN had revenue of EUR 214.13 million and earned 41.41 million in profits. Earnings per share was 2.12.

Revenue	214.13M
Gross Profit	131.89M
Operating Income	24.59M
Pretax Income	53.68M
Net Income	41.41M
EBITDA	53.72M
EBIT	24.59M
Earnings Per Share (EPS)	2.12

Balance Sheet

The company has 566.37 million in cash and 384.38 million in debt, giving a net cash position of 181.99 million.

Cash & Cash Equivalents	566.37M
Total Debt	384.38M
Net Cash	181.99M
Net Cash Per Share	n/a
Equity (Book Value)	809.83M
Book Value Per Share	41.20
Working Capital	616.54M

Cash Flow

In the last 12 months, operating cash flow was 27.20 million and capital expenditures -984,407, giving a free cash flow of 26.22 million.

Operating Cash Flow	27.20M
Capital Expenditures	-984,407
Free Cash Flow	26.22M
FCF Per Share	n/a

Margins

Gross margin is 61.59%, with operating and profit margins of 11.48% and 19.34%.

Gross Margin	61.59%
Operating Margin	11.48%
Pretax Margin	25.07%
Profit Margin	19.34%
EBITDA Margin	25.09%
EBIT Margin	11.48%
FCF Margin	12.24%

Dividends & Yields

FRA:LGDN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.20%
Shareholder Yield	-6.20%
Earnings Yield	1.24%
FCF Yield	0.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 19, 2010. It was a reverse split with a ratio of 0.16667.

Last Split Date	Nov 19, 2010
Split Type	Reverse
Split Ratio	0.16667

Scores

FRA:LGDN has an Altman Z-Score of 4 and a Piotroski F-Score of 5.

Altman Z-Score	4
Piotroski F-Score	5